A Deconsolution for disinfection of highly resistant strains of E. coli that have emerged including O157:H7 and ESBL (Extended-Spectrum Beta Lactamases). Since 2003, new highly resistant strains of the bacterium Escherichia coli have become widespread. These strains of E. coli are able to destroy a large number of common antibiotics, making the infections they cause very difficult to treat. The bacteria produce enzymes called extended-spectrum β-lactamases (ESBLs) that destroy, and confer resistance to, antibiotics. ESBL-producing microbes are not new, having first been recognized in the 1980s. But the new strains produce a particular type of ESBL, the CTX-M type, which is able to break down a wider range of antibiotics. Further, recent outbreaks in agricultural products have been directly linked to E. coli O157:H7 strain, a more difficult strain to deactivate and kill.

Product Description Highly efficacious and environmentally safe, Jymrsa's E. coli Disinfection Products are produced exclusively by Modec, Inc. and compounded specifically for the neutralization of these high level strains of Escherichia coli.

Technology The US Government developed the underlying technology at Sandia National Laboratories and patented the Formulation pursuant to US Patent 6,566,574 B1. Jymrsa's Disinfection products are commercially manufactured by Modec pursuant to its license 00-C00872 with Sandia Corp.

Sandia Agricultural Decontamination Study (pdf)

Marketed and Distributed Exclusively by (Click on Logo):

Modec, Inc., 4725 Oakland Street, Denver, Colorado USA 80239 1-800-967-7887 - 303-373-2696